A citation-based method for searching scientific literature

Nozomi Nakajima, Sumihito Nobusawa, Satoshi Nakata, Mitsutoshi Nakada, Tatsuya Yamazaki, Nozomi Matsumura, Kenichi Harada, Hadzki Matsuda, Nobuaki Funata, Shoichi Nagai, Hideo Nakamura, Atsushi Sasaki, Jiro Akimoto, Junko Hirato, Hideaki Yokoo. Brain Pathol 2018
Times Cited: 28







List of co-cited articles
115 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Epithelioid GBMs show a high percentage of BRAF V600E mutation.
Bette Kay Kleinschmidt-DeMasters, Dara L Aisner, Diane K Birks, Nicholas K Foreman. Am J Surg Pathol 2013
157
60

Epithelioid glioblastomas stratify into established diagnostic subsets upon integrated molecular analysis.
Andrey Korshunov, Lukas Chavez, Tanvi Sharma, Marina Ryzhova, Daniel Schrimpf, Damian Stichel, David Capper, Dominik Sturm, Marcel Kool, Antje Habel,[...]. Brain Pathol 2018
57
46

Epithelioid Glioblastomas and Anaplastic Epithelioid Pleomorphic Xanthoastrocytomas--Same Entity or First Cousins?
Sanda Alexandrescu, Andrey Korshunov, Siang Hui Lai, Salma Dabiri, Sushama Patil, Rong Li, Chie-Schin Shih, Jose M Bonnin, Jonathan A Baker, Emma Du,[...]. Brain Pathol 2016
64
42

Epithelioid glioblastoma arising from pleomorphic xanthoastrocytoma with the BRAF V600E mutation.
Shingo Tanaka, Mitsutoshi Nakada, Sumihito Nobusawa, Satoshi O Suzuki, Hemragul Sabit, Katsuyoshi Miyashita, Yutaka Hayashi. Brain Tumor Pathol 2014
48
42

The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.
David N Louis, Arie Perry, Guido Reifenberger, Andreas von Deimling, Dominique Figarella-Branger, Webster K Cavenee, Hiroko Ohgaki, Otmar D Wiestler, Paul Kleihues, David W Ellison. Acta Neuropathol 2016
35

Concurrent TERT promoter and BRAF V600E mutation in epithelioid glioblastoma and concomitant low-grade astrocytoma.
Nozomi Matsumura, Nozomi Nakajima, Tatsuya Yamazaki, Takuro Nagano, Kaie Kagoshima, Sumihito Nobusawa, Hayato Ikota, Hideaki Yokoo. Neuropathology 2017
30
32

Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma.
Genevieve Schindler, David Capper, Jochen Meyer, Wibke Janzarik, Heymut Omran, Christel Herold-Mende, Kirsten Schmieder, Pieter Wesseling, Christian Mawrin, Martin Hasselblatt,[...]. Acta Neuropathol 2011
655
32

Epithelioid versus rhabdoid glioblastomas are distinguished by monosomy 22 and immunohistochemical expression of INI-1 but not claudin 6.
Bette Kay Kleinschmidt-DeMasters, Ali H Alassiri, Diane K Birks, Kathy L Newell, Wayne Moore, Kevin O Lillehei. Am J Surg Pathol 2010
70
28

A case of an epithelioid glioblastoma with the BRAF V600E mutation colocalized with BRAF intact low-grade diffuse astrocytoma.
Jun-Ichiro Kuroda, Sumihito Nobusawa, Hideo Nakamura, Hideaki Yokoo, Ryuta Ueda, Keishi Makino, Shigetoshi Yano, Jun-ichi Kuratsu. Neuropathology 2016
16
50

Clinical, radiological, histological and molecular characteristics of paediatric epithelioid glioblastoma.
A Broniscer, R G Tatevossian, N D Sabin, P Klimo, J Dalton, R Lee, A Gajjar, D W Ellison. Neuropathol Appl Neurobiol 2014
65
28

Pleomorphic Xanthoastrocytoma: Natural History and Long-Term Follow-Up.
Cristiane M Ida, Fausto J Rodriguez, Peter C Burger, Alissa A Caron, Sarah M Jenkins, Grant M Spears, Dawn L Aranguren, Daniel H Lachance, Caterina Giannini. Brain Pathol 2015
121
25

Dabrafenib Treatment in a Patient with an Epithelioid Glioblastoma and BRAF V600E Mutation.
Garry Ceccon, Jan-Michael Werner, Veronika Dunkl, Caroline Tscherpel, Gabriele Stoffels, Anna Brunn, Martina Deckert, Gereon R Fink, Norbert Galldiks. Int J Mol Sci 2018
18
38

Dramatic response of BRAF V600E-mutant epithelioid glioblastoma to combination therapy with BRAF and MEK inhibitor: establishment and xenograft of a cell line to predict clinical efficacy.
Yu Kanemaru, Manabu Natsumeda, Masayasu Okada, Rie Saito, Daiki Kobayashi, Takeyoshi Eda, Jun Watanabe, Shoji Saito, Yoshihiro Tsukamoto, Makoto Oishi,[...]. Acta Neuropathol Commun 2019
12
58

Recurrent copy number alterations in low-grade and anaplastic pleomorphic xanthoastrocytoma with and without BRAF V600E mutation.
Rachael A Vaubel, Alissa A Caron, Seiji Yamada, Paul A Decker, Jeanette E Eckel Passow, Fausto J Rodriguez, Amulya A Nageswara Rao, Daniel Lachance, Ian Parney, Robert Jenkins,[...]. Brain Pathol 2018
39
21

Intratumoral heterogeneity of genomic imbalance in a case of epithelioid glioblastoma with BRAF V600E mutation.
Sumihito Nobusawa, Junko Hirato, Hideyuki Kurihara, Akira Ogawa, Naoki Okura, Masaya Nagaishi, Hayato Ikota, Hideaki Yokoo, Yoichi Nakazato. Brain Pathol 2014
30
21

Clinicopathological and genetic association between epithelioid glioblastoma and pleomorphic xanthoastrocytoma.
Takuya Furuta, Hiroaki Miyoshi, Satoru Komaki, Fumiko Arakawa, Motohiro Morioka, Koichi Ohshima, Mitsutoshi Nakada, Yasuo Sugita. Neuropathology 2018
19
31

Epithelioid/rhabdoid glioblastoma: a highly aggressive subtype of glioblastoma.
Kazutaka Sugimoto, Makoto Ideguchi, Tokuhiro Kimura, Koji Kajiwara, Hirochika Imoto, Hirokazu Sadahiro, Aya Ishii, Hiroo Kawano, Eiji Ikeda, Michiyasu Suzuki. Brain Tumor Pathol 2016
24
25

Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors.
Jeanette E Eckel-Passow, Daniel H Lachance, Annette M Molinaro, Kyle M Walsh, Paul A Decker, Hugues Sicotte, Melike Pekmezci, Terri Rice, Matt L Kosel, Ivan V Smirnov,[...]. N Engl J Med 2015
990
17

Therapeutic and Prognostic Implications of BRAF V600E in Pediatric Low-Grade Gliomas.
Alvaro Lassaletta, Michal Zapotocky, Matthew Mistry, Vijay Ramaswamy, Marion Honnorat, Rahul Krishnatry, Ana Guerreiro Stucklin, Nataliya Zhukova, Anthony Arnoldo, Scott Ryall,[...]. J Clin Oncol 2017
122
17

BRAF V600E mutations are common in pleomorphic xanthoastrocytoma: diagnostic and therapeutic implications.
Dora Dias-Santagata, Quynh Lam, Kathy Vernovsky, Natalie Vena, Jochen K Lennerz, Darrell R Borger, Tracy T Batchelor, Keith L Ligon, A John Iafrate, Azra H Ligon,[...]. PLoS One 2011
209
17

Immunohistochemical and molecular genetic study on epithelioid glioblastoma: Series of seven cases with review of literature.
Gaurav Khanna, Pankaj Pathak, Vaishali Suri, Mehar Chand Sharma, Sujata Chaturvedi, Arvind Ahuja, M Bhardwaj, Ajay Garg, Chitra Sarkar, Rajeev Sharma. Pathol Res Pract 2018
13
38

BRAF Inhibition in BRAFV600-Mutant Gliomas: Results From the VE-BASKET Study.
Thomas Kaley, Mehdi Touat, Vivek Subbiah, Antoine Hollebecque, Jordi Rodon, A Craig Lockhart, Vicki Keedy, Franck Bielle, Ralf-Dieter Hofheinz, Florence Joly,[...]. J Clin Oncol 2018
108
17

A case of osteoclast-like giant cell-rich epithelioid glioblastoma with BRAF V600E mutation.
Nobuaki Funata, Sumihito Nobusawa, Ryoji Yamada, Nobusada Shinoura. Brain Tumor Pathol 2016
14
28

BRAF mutation and CDKN2A deletion define a clinically distinct subgroup of childhood secondary high-grade glioma.
Matthew Mistry, Nataliya Zhukova, Daniele Merico, Patricia Rakopoulos, Rahul Krishnatry, Mary Shago, James Stavropoulos, Noa Alon, Jason D Pole, Peter N Ray,[...]. J Clin Oncol 2015
166
14

Distribution of TERT promoter mutations in pediatric and adult tumors of the nervous system.
Christian Koelsche, Felix Sahm, David Capper, David Reuss, Dominik Sturm, David T W Jones, Marcel Kool, Paul A Northcott, Benedikt Wiestler, Katja Böhmer,[...]. Acta Neuropathol 2013
191
14

TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal.
Patrick J Killela, Zachary J Reitman, Yuchen Jiao, Chetan Bettegowda, Nishant Agrawal, Luis A Diaz, Allan H Friedman, Henry Friedman, Gary L Gallia, Beppino C Giovanella,[...]. Proc Natl Acad Sci U S A 2013
871
14


Regulation of mutant TERT by BRAF V600E/MAP kinase pathway through FOS/GABP in human cancer.
Rengyun Liu, Tao Zhang, Guangwu Zhu, Mingzhao Xing. Nat Commun 2018
83
14

CDKN2A loss is associated with shortened overall survival in lower-grade (World Health Organization Grades II-III) astrocytomas.
Gerald F Reis, Melike Pekmezci, Helen M Hansen, Terri Rice, Roxanne E Marshall, Annette M Molinaro, Joanna J Phillips, Hannes Vogel, John K Wiencke, Margaret R Wrensch,[...]. J Neuropathol Exp Neurol 2015
69
14

BRAF-mutated pleomorphic xanthoastrocytoma is associated with temporal location, reticulin fiber deposition and CD34 expression.
Christian Koelsche, Felix Sahm, Adelheid Wöhrer, Astrid Jeibmann, Jens Schittenhelm, Patricia Kohlhof, Matthias Preusser, Bernd Romeike, Hildegard Dohmen-Scheufler, Christian Hartmann,[...]. Brain Pathol 2014
51
14

The genetic landscape of anaplastic pleomorphic xanthoastrocytoma.
Joanna J Phillips, Henry Gong, Katharine Chen, Nancy M Joseph, Jessica van Ziffle, Boris C Bastian, James P Grenert, Cassie N Kline, Sabine Mueller, Anuradha Banerjee,[...]. Brain Pathol 2019
42
14

BRAF VE1 immunoreactivity patterns in epithelioid glioblastomas positive for BRAF V600E mutation.
Bette K Kleinschmidt-DeMasters, Dara L Aisner, Nicholas K Foreman. Am J Surg Pathol 2015
43
14

Rhabdoid glioblastoma in a child: case report and literature review.
Hiroyuki Momota, Kenichiro Iwami, Masazumi Fujii, Kazuya Motomura, Atsushi Natsume, Jiro Ogino, Tadashi Hasegawa, Toshihiko Wakabayashi. Brain Tumor Pathol 2011
20
20

Rhabdoid glioblastoma: case report and literature review.
Miao-Xia He, Jian-Jun Wang. Neuropathology 2011
20
20

Rapid Clinical and Radiographic Response With Combined Dabrafenib and Trametinib in Adults With BRAF-Mutated High-Grade Glioma.
Tanner M Johanns, Cole J Ferguson, Patrick M Grierson, Sonika Dahiya, George Ansstas. J Natl Compr Canc Netw 2018
30
14

Epithelial and pseudoepithelial differentiation in glioblastoma and gliosarcoma: a comparative morphologic and molecular genetic study.
Fausto J Rodriguez, Bernd W Scheithauer, Caterina Giannini, Sandra C Bryant, Robert B Jenkins. Cancer 2008
60
14

Confirming Diagnosis and Effective Treatment for Rare Epithelioid Glioblastoma Variant: An Integrated Survival Analysis of the Literature.
Victor M Lu, Naveen D George, Desmond A Brown, Oluwaseun O Akinduro, Aditya Raghunathan, Mark Jentoft, Alfredo Quinones-Hinojosa, Kaisorn L Chaichana. World Neurosurg 2019
6
66

Integrated analysis of pediatric glioblastoma reveals a subset of biologically favorable tumors with associated molecular prognostic markers.
Andrey Korshunov, Marina Ryzhova, Volker Hovestadt, Sebastian Bender, Dominik Sturm, David Capper, Jochen Meyer, Daniel Schrimpf, Marcel Kool, Paul A Northcott,[...]. Acta Neuropathol 2015
188
10

Patterns of care and outcomes of patients with pleomorphic xanthoastrocytoma: a SEER analysis.
Stephanie M Perkins, Nandita Mitra, Wan Fei, Eric T Shinohara. J Neurooncol 2012
56
10

Mutations of the BRAF gene in human cancer.
Helen Davies, Graham R Bignell, Charles Cox, Philip Stephens, Sarah Edkins, Sheila Clegg, Jon Teague, Hayley Woffendin, Mathew J Garnett, William Bottomley,[...]. Nature 2002
10

Frequent loss of chromosome 9, homozygous CDKN2A/p14(ARF)/CDKN2B deletion and low TSC1 mRNA expression in pleomorphic xanthoastrocytomas.
R G Weber, A Hoischen, M Ehrler, P Zipper, K Kaulich, B Blaschke, A J Becker, S Weber-Mangal, A Jauch, B Radlwimmer,[...]. Oncogene 2007
72
10

Frequency of TERT promoter mutations in human cancers.
João Vinagre, Ana Almeida, Helena Pópulo, Rui Batista, Joana Lyra, Vasco Pinto, Ricardo Coelho, Ricardo Celestino, Hugo Prazeres, Luis Lima,[...]. Nat Commun 2013
535
10

Prognostic factors and therapeutic outcomes in 22 patients with pleomorphic xanthoastrocytoma.
Sungryong Lim, Jeong Hoon Kim, Sun A Kim, Eun Suk Park, Young Shin Ra, Chang Jin Kim. J Korean Neurosurg Soc 2013
27
11

Biomarker-based prognostic stratification of young adult glioblastoma.
Rui-Qi Zhang, Zhifeng Shi, Hong Chen, Nellie Yuk-Fei Chung, Zi Yin, Kay Ka-Wai Li, Danny Tat-Ming Chan, Wai Sang Poon, Jinsong Wu, Liangfu Zhou,[...]. Oncotarget 2016
25
12

EZH2 expression in gliomas: Correlation with CDKN2A gene deletion/ p16 loss and MIB-1 proliferation index.
Suvendu Purkait, Vikas Sharma, Prerana Jha, Mehar Chand Sharma, Vaishali Suri, Ashish Suri, B S Sharma, Chitra Sarkar. Neuropathology 2015
12
25

Glioblastoma with Rhabdoid Features: Report of Two Young Adult Cases and Review of the Literature.
Makiko Miyahara, Sumihito Nobusawa, Masato Inoue, Kouichiro Okamoto, Makoto Mochizuki, Tetsuo Hara. World Neurosurg 2016
9
33

Concurrent BRAF/MEK Inhibitors in BRAF V600-Mutant High-Grade Primary Brain Tumors.
Karisa C Schreck, Andrew Guajardo, Doris D M Lin, Charles G Eberhart, Stuart A Grossman. J Natl Compr Canc Netw 2018
22
13

Dabrafenib and trametinib in BRAFV600E mutated glioma.
Nicholas F Brown, Thomas Carter, Neil Kitchen, Paul Mulholland. CNS Oncol 2017
31
10

Clinicopathological characteristics and treatment of rhabdoid glioblastoma.
Ranjith Babu, Jeffrey Hatef, Roger E McLendon, Thomas J Cummings, John H Sampson, Allan H Friedman, Cory Adamson. J Neurosurg 2013
21
14

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma.
Roger Stupp, Warren P Mason, Martin J van den Bent, Michael Weller, Barbara Fisher, Martin J B Taphoorn, Karl Belanger, Alba A Brandes, Christine Marosi, Ulrich Bogdahn,[...]. N Engl J Med 2005
10


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.